Title

Annals of Oncology

2024
- September
  - Volume 35
    - Issue 9
- August
  - Volume 35
    - Issue 8
- July
  - Volume 35
    - Issue 7
- June
  - Volume 35
    - Issue 6
- May
  - Volume 35
    - Issue 5
- April
  - Volume 35
    - Issue 4
- March
  - Volume 35
    - Issue 3
- February
  - Volume 35
    - Issue 2
- January
  - Volume 35
    - Issue 1
2023
- December
  - Volume 34
    - Issue 12
- November
  - Volume 34
    - Issue 11
- October
  - Volume 34
    - Issue 10
- September
  - Volume 34
    - Issue 9
- August
  - Volume 34
    - Issue 8
- July
  - Volume 34
    - Issue 7
- June
  - Volume 34
    - Issue 6
- May
  - Volume 34
    - Issue 5
- April
  - Volume 34
    - Issue 4
- March
  - Volume 34
    - Issue 3
- February
  - Volume 34
    - Issue 2
- January
  - Volume 34
    - Issue 1
2022
- December
  - Volume 33
    - Issue 12
- November
  - Volume 33
    - Issue 11
- October
  - Volume 33
    - Issue 10
- September
  - Volume 33
    - Issue 9
- August
  - Volume 33
    - Issue 8
- July
  - Volume 33
    - Issue 7
- June
  - Volume 33
    - Issue 6
- May
  - Volume 33
    - Issue 5
  - Volume 32
- April
  - Volume 33
    - Issue 4
- March
  - Volume 33
    - Issue 3
- February
  - Volume 33
    - Issue 2
- January
  - Volume 33
    - Issue 1
2021
- December
  - Volume 32
    - Issue 12
- November
  - Volume 32
    - Issue 11
- October
  - Volume 32
    - Issue 10
- September
  - Volume 32
    - Issue 9
- August
  - Volume 32
    - Issue 8
- July
  - Volume 32
    - Issue 7
- June
  - Volume 32
    - Issue 6
- May
  - Volume 32
    - Issue 5
- April
  - Volume 32
    - Issue 4
- March
  - Volume 32
    - Issue 3
- February
  - Volume 32
    - Issue 2
- January
  - Volume 32
    - Issue 1

Medilib Journal is a reliable source of researches and researches in the field of medicine. The philosophy of journals is to preserve scientific materials and register them in the name of the author and prevent plagiarism.

Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.